Partner
Ken Pastor
Managing Partner, CTI Life Sciences Fund
- Firm
- CTI Life Sciences Fund
- Title
- Managing Partner
- Role
- Managing partner
- Known as
- Investor
Claim, correct or request removal
Record updated 29 September 2026
About
Ken serves as the Founding General Partner of CTI LFS, with a distinguished tenure of over 20 years with the firm. Throughout his extensive career, he has overseen all the investments made by CTI. Ken was responsible for building GLyPharma, one of CTI's most important success stories. GLyPharma transacted in equity with Theracon, which Pfizer purchased. Ken subsequently took the original GLyPharma asset and established VectivBio, which Ironwood recently purchased for >$1B. He was also responsible for many of CTI’s key transactions.
Is this you? Remove my profile
Loading relationship preview